EDWARDS INTUITY Valve System CADENCE Study

Aortic Stenosis Clinical Trial

— CADENCE  

Official title:

A Randomized Comparison of the EDWARDS INTUITY Valve System anD commErcially Available Aortic Bioprostheses in Subjects uNdergoing surgiCal Aortic Valve replacEment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02688153
• Other study ID #: 2011-11
• Status: Completed
• Phase: N/A
• Start date: October 2012
• Est. completion date: April 2016

Study information

• Verified date: May 2018
• Source: Edwards Lifesciences
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study purpose is to compare the EDWARDS INTUITY valve system with commercially available stented aortic bioprostheses, in patients requiring aortic valve replacement surgery with coronary artery bypass.

Description:

This is a randomized study comparing the cross-clamp time (XCT) and cardiopulmonary bypass time (CPBT) of the EDWARDS INTUITY valve system with any commercially available stented aortic bioprosthesis, in patients with logistic EuroSCORE 1 ≥ 6 undergoing elective surgical aortic valve replacement surgery with concomitant coronary bypass grafts.

Additionally, the aim is to gather sufficient data to quantify the effect size of short term patient benefit outcomes previously identified from literature and finally to explore additional healthcare resource utilization or health economic endpoints.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: April 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion:

• =18 years of age

• aortic stenosis / mixed aortic stenosis and aortic insufficiency

• SAVR+CABG (1-4 distal anastomoses)

• Log. EuroSCORE =6

• NYHA Class =II

Exclusion (i.a.):

• pure aortic insufficiency

• pre-existing prosthetic heart valve or ring

• congenital true bicuspid / unicuspid aortic valve

• LVEF <20%

Related Conditions & MeSH terms

• Aortic Stenosis
• Aortic Valve Disease
• Aortic Valve Stenosis

Intervention

Device:
• EDWARDS INTUITY
To evaluate cardiac performance characteristics and adverse events rates associated with the EDWARDS INTUITY Valve in patients undergoing AVR & CABG.
• Stented aortic bioprostheses
In comparison to control valves available on the market.

Locations

Country	Name	City	State
France	CHU Bordeaux, Hôpital Haut-Lévêque	Pessac

Sponsors (1)

Lead Sponsor	Collaborator
Edwards Lifesciences

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Average Subject Time Spent on Cardiopulmonary Cross Clamp	Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.	At time of surgery, an average of 1.5 hours
Primary	Average Amount of Time Subject Spent on Cardiopulmonary Bypass	Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.	At time of surgery, an average of 2 hours
Secondary	Number of Participants With Change From Baseline in New York Heart Association (NYHA) Class at 2 Years.	The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life. Class I. Patients with cardiac disease but without resulting limitation of physical activity.; Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.; Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.; Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.; Symptoms of heart failure or the anginal syndrome may be present even at rest.	Baseline and 2 Years
Secondary	Subject's Average Mean Gradients (mmHg) Measurements Over Time.	Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subject's Average Peak Gradients (mmHg) Measurements Over Time.	Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.	30 days, 3 months, 6 months, 1 year, 2 year
Secondary	Subject's Effective Orifice Area (EOA) Measurement Over Time.	Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.	30 days, 3 months, 6 months, 1 year, 2 year
Secondary	Subject's Effective Orifice Area Index (EOAI) Measurement Over Time.	Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.	30 days, 3 months, 6 months, 1 year, 2 year
Secondary	Amount of Aortic Valvular Regurgitation Over Time.	Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 represents no regurgitation and 4 represents severe regurgitation.	30 days, 3 months, 6 months, 1 year, 2 year
Secondary	Conversion of Edwards INTUITY Surgical Aortic Valve to Control During Surgery.	Subjects randomized to the Edwards INTUITY group that were converted to the control group and received commercially available surgical aortic heart valves during surgery.	Prior to Surgery
Secondary	Subjects Who Required a Thoracic Resternotomy Over Time	Number of Subjects who had a surgical opening of their chest after their initial aortic heart valve surgery shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects Who Received a Permanent Pacemaker Over Time.	Number of Subjects who received a Permanent Pacemaker shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Major Paravalvular Leak (OPC) Over Time	Number of subjects who experienced a Major Paravalvular Leak (OPC) shown over various time points.; Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing.; Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. A major paravalvular leak (OPC)are any events of leak that required surgical intervention or were considered an serious adverse event.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects Who Experienced Major Bleeding Over Time.	Number of subjects who experienced Major Bleeding shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects Who Experienced Respiratory Failure Over Time	Number of subjects who experienced a Respiratory Failure shown over various time points. Respiratory failure happens when not enough oxygen passes from your lungs to your blood.	30 days, 3 Months , 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Cerebral Vascular Accident or Permanent Stroke Over Time	Number of subjects who experienced a Cerebral Vascular Accident or Permanent Stroke shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With Renal Failure Over Time	Number of subjects who experienced Renal (kidney) Failure shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With Endocarditis Over Time	Number of subjects who experienced Endocarditis shown over various time points. Endocarditis is an infection of the endocardium, which is the inner lining of your heart chambers and heart valves.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Deep Sternal Would Infection Over Time	Number of subjects who experienced a Deep Sternal Wound Infection shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Myocardial Infarction Over Time	Number of subjects who experienced a Myocardial Infarction shown over various time points. A Myocardial infarction, commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Thromboembolism Over Time	Number of subjects who experienced a Thromboembolism shown over various time points. A thromboembolism is an obstruction of a blood vessel by a blood clot that has become dislodged from another site in the circulation.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Cardiac Tamponade Over Time	Number of subjects who experienced a Cardiac Tamponade shown over various time points. Cardiac tamponade is when fluid in the pericardium (the sac around the heart) builds up and results in compression (squeezing) of the heart.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects With a Cardiac Reoperation for Any Reason Over Time	Number of subjects who experienced a Cardiac reoperation for any reason shown over various time points.	30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subjects Who Died Intraoperatively	Number of subjects who died during surgery.	Surgery
Secondary	Subject's Average Score on the EQ-5D- Quality of Life Questionnaire Over Time	The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.	Baseline, 30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subject's Average Score SF-12 - Quality of Life Questionnaire Over Time	The Medical Outcomes Study Short-Form 12 (SF-12) - Physical Component Summary (PCS) and Mental Component Summary (MCS).; The SF-12 questionnaire scale ranges from 100, which reflects the best health status to 0, which reflects the worse health status.; Subject's Average Score at Baseline and at each follow-up interval until 2 year - SF-12.	Baseline, 30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Subject's Average Score on the KCCQ - Quality of Life Questionnaire Over Time	The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. Scores range from 0-100, in which higher scores reflect better health status. Subjects took this questionnaire at baseline, 30 days, 3 Months, 6 Months, 1 Year, and 2 Years.	Baseline, 30 days, 3 Months, 6 Months, 1 Year, 2 Years.
Secondary	Health Care Utilization	The average amount of time the subjects spent in the intensive care unit, the intermediate care length of stay, and the average total length of hospital stay after their heart valve replacement procedure.	Day of surgical procedure through discharge from the hospital, an average of 2 weeks

External Links

•   EuroQol Standardized Instrument (EQ-5D) developed to measure of health-related quality of life.
•   Kansas City Cardiomyopathy Questionnaire (KCCQ)
•   New York Heart Association Classification
•   Short Form Health Survey (SF-12) with 12 questions to measure functional health and well-being of patient's quality of life